ArticleHepatology (Baltimore, Md.)2016

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.

Mei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.